4D Radiotherapy Equipment Market Report 2026

The 4D radiotherapy equipment market size has grown strongly in recent years. It will grow from $1.91 billion in 2025 to $2.09 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increasing demand for motion-adaptive radiation therapy, growing adoption of advanced imaging systems, rising focus on minimizing treatment errors, expanding use of real-time patient monitoring, increasing preference for high-precision radiotherapy.

The 4D radiotherapy equipment market size is expected to see strong growth in the next few years. It will grow to $2.99 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to growing investment in next-generation radiotherapy technologies, increasing adoption of 4D treatment systems, rising demand for accurate tumor-tracking solutions, expanding integration of ai-enabled motion management, increasing need for personalized radiation therapy. Major trends in the forecast period include technology advancements in motion-synchronized radiotherapy systems, innovations in real-time imaging capabilities, developments in adaptive treatment delivery platforms, research and development in tumor-tracking technologies, advancements in imaging-guided radiotherapy solutions.

The rising prevalence of cancer is expected to drive the growth of the 4D radiotherapy equipment market going forward. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells, which can damage surrounding tissues and organs if not treated effectively. The prevalence of cancer is increasing due to lifestyle-related risk factors such as poor diet, smoking, alcohol consumption, and exposure to environmental pollutants, elevating the likelihood of developing various cancers. 4D radiotherapy equipment helps manage cancer by delivering highly precise, motion-adapted radiation treatments that account for tumor movement during breathing. It improves patient outcomes by maximizing tumor targeting, minimizing damage to healthy tissues, and enhancing treatment effectiveness. For instance, in October 2025, according to NHS Digital, a UK government organisation, there were 354,820 new cancer diagnoses recorded in England in 2023, averaging 972 diagnoses per day and representing an increase of 8,605 cases compared to 2022, with prostate cancer being the most commonly diagnosed cancer at 58,137 new cases, reflecting a 6% increase in registrations compared to the previous year. Therefore, the rising prevalence of cancer is driving the growth of the 4D radiotherapy equipment market.

The rising healthcare spending is also expected to propel the growth of the 4D radiotherapy equipment market going forward. Healthcare spending in emerging markets refers to investments made by governments, private institutions, and healthcare providers to improve medical infrastructure, access to advanced treatments, and patient care services. Spending is increasing as growing middle-class populations experience higher incomes and longer lifespans, driving demand for better medical services, hospital infrastructure, and insurance coverage. 4D radiotherapy equipment supports this trend by providing precise, image-guided radiation treatment that accounts for tumor motion, improving treatment outcomes while minimizing damage to surrounding healthy tissue. For instance, in June 2025, according to Statistics Austria, the national statistical office of Austria, total healthcare expenditure in Austria reached approximately $61.6 billion (€57 billion) in 2024, contributed by both public and private sectors, representing an increase of about $4.6 billion (€4.25 billion) compared to the previous year. The share of healthcare spending as a proportion of gross domestic product also rose from 11.2% in 2023 to 11.8% in 2024. Therefore, rising healthcare spending in emerging markets is driving the growth of the 4D radiotherapy equipment market.

Leading companies operating in the 4D radiotherapy equipment market are focusing on developing high-definition imaging systems, such as AI‑powered CT‑Linac platforms, to enhance treatment precision, enable real-time plan adjustments, and improve workflow efficiency. AI‑powered CT‑Linac platforms are integrated computed tomography-linear accelerator systems that utilize artificial intelligence for high-definition imaging, adaptive treatment planning, and real-time dose adjustment to deliver highly precise, personalized radiation therapy for cancer patients. For instance, in May 2024, Elekta AB, a Sweden-based medical technology company, launched Elekta Evo, a CT‑Linac featuring AI-enhanced imaging and online/offline adaptive radiotherapy capabilities. This system allows clinicians to visualize target anatomy with exceptional clarity and adjust radiation delivery on a per-session basis to account for motion and anatomical changes. The launch represents a significant technological advancement by integrating high-precision imaging and adaptive therapy into routine clinical workflows, bridging traditional radiotherapy with AI-driven adaptive 4D planning, and providing clinicians with a scalable, efficient solution for improved patient outcomes.

Major companies operating in the 4D radiotherapy equipment market are Hitachi Ltd., Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Varian Medical Systems Inc., Elekta AB, Shanghai United Imaging Healthcare Co. Ltd., Accuray Incorporated, Brainlab AG, Canon Medical Systems Corporation, RefleXion Medical, Vision RT Ltd., C-Rad AB, MVision AI Ltd., Anzai Medical Co. Ltd., ViewRay Technologies Inc., DYN’R Medical Systems, Ion Beam Applications SA (IBA SA)

North America was the largest region in the 4D radiotherapy equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the 4D radiotherapy equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the 4D radiotherapy equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are influencing the 4D radiotherapy equipment market by increasing costs of imported linear accelerators, imaging modules, motion management systems, sensors, and treatment planning software hardware. cancer treatment centers in north america and europe are most affected due to reliance on imported high-end radiotherapy systems, while asia-pacific faces increased installation and upgrade costs. these tariffs are raising capital investment requirements and slowing equipment replacement cycles. however, they are also encouraging localized assembly, regional manufacturing partnerships, and domestic development of advanced radiotherapy technologies.

4D radiotherapy equipment refers to advanced radiation therapy systems designed to account for tumor motion over time, typically caused by patient breathing or organ movement. Its primary objective is to deliver precise, targeted radiation doses to moving tumors while minimizing exposure to surrounding healthy tissues, thereby enhancing treatment efficacy and patient safety.

The main product types or components of four-dimensional radiotherapy equipment include 4D gating or radiotherapy systems, linear accelerators, 4D imaging modalities, surface-guided radiation therapy systems, and treatment planning software. 4D gating or radiotherapy systems are advanced motion-controlled platforms developed to synchronize radiation delivery with patient or tumor movement to improve targeting precision. These systems utilize motion-management methods such as respiratory gating, real-time tumor tracking, breath-hold techniques, and adaptive radiotherapy. They are used in applications such as lung cancer, liver cancer, pancreatic cancer, breast cancer, lymphoma, and other cancers, and are adopted by end users such as hospitals, cancer treatment centers, specialty radiotherapy clinics, and research institutions.

The 4D radiotherapy equipment market consists of revenues earned by entities by providing services such as motion-managed treatment planning, real-time tumor tracking, respiratory-gated radiotherapy, treatment plan verification and optimization, patient-specific dose monitoring, and technical support and training. The market value includes the value of related goods sold by the equipment manufacturer or included within the equipment offering. The 4D radiotherapy equipment market also includes sales of 4D linear accelerators, motion-tracking imaging systems, respiratory-gated radiotherapy devices, treatment planning software, and patient positioning and immobilization systems. Values in this market are ‘factory gate’ values, meaning the value of goods sold by the manufacturers or creators of the equipment, whether to other entities or directly to end customers. The value of goods in this market includes related services sold by the creators of the equipment.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.